Work

Abstract A218: Pharmacokinetics of orally administered rucaparib in patients with advanced solid tumors.

Year: 2013

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-13-a218

Authors: Geoffrey Shapiro, Rebecca Kristeleit, Mark Middleton, Howard Burris, L. Rhoda Molife, Jeff Evans, Richard Wilson, Patricia LoRusso, James Spicer, Veronique Dieras, Manish Patel, Erin Dominy, Dayna Simpson, Heidi Giordano, Andrew R. Allen, Sarah S. Jaw-Tsai, Ruth Plummer

Institutions: Dana-Farber Cancer Institute, University College London, Oxford University Hospitals NHS Trust, Sarah Cannon, Beatson West of Scotland Cancer Centre, The Northern Ireland Cancer Centre, The Barbara Ann Karmanos Cancer Institute, King's College London, Institut Curie, Clovis Oncology (United Kingdom), Newcastle University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1973695302

Cites:

Cited by: 11

Related to: 10